SCHEMBL12396664

SCHEMBL12396664

Cc1ccc(S(=O)(=O)OCC(=O)[C@@]2(O)CCC3C4CCC5=CC(=O)CCC5(C)C4[C@@H](O)CC32C)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HIF1A Q16665 10/20 0.71
▸ PGR P06401 2/20 0.71
▸ SERPINA6 P08185 2/20 0.71
▸ LMNA P02545 2/20 0.71
▸ AR P10275 1/20 0.71
▸ CHRM1 P11229 1/20 0.71
▸ NR3C1 P04150 9/20 0.69
▸ SMN1; SMN2 Q16637 3/20 0.69
▸ CYP2C19 P33261 2/20 0.69
▸ HSD17B10 Q99714 2/20 0.69
▸ CYP3A4 P08684 2/20 0.69
▸ NFKB1 P19838 2/20 0.69
▸ MAPT P10636 2/20 0.69
▸ SHBG P04278 1/20 0.69
▸ NR3C2 P08235 1/20 0.69
▸ KMT2A Q03164 1/20 0.69
▸ PMP22 Q01453 1/20 0.67
▸ TSHR P16473 1/20 0.67
▸ POLB P06746 1/20 0.64
▸ GAA P10253 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9073513 1.00 HIF1A (0.71) HIF1APGRSERPINA6LMNAAR
SCHEMBL2803362 0.88 HIF1A (0.78) HIF1APGRSERPINA6LMNAAR
SCHEMBL11144452 0.88 HIF1A (0.78) HIF1APGRSERPINA6LMNAAR
SCHEMBL332584 0.88 HIF1A (0.78) HIF1APGRSERPINA6LMNAAR
SCHEMBL11281433 0.88 HIF1A (0.78) HIF1APGRSERPINA6LMNAAR
SCHEMBL12235695 0.88 HIF1A (0.78) HIF1APGRSERPINA6LMNAAR
SCHEMBL13692155 0.87 HIF1A (0.79) HIF1APGRSERPINA6LMNAAR
SCHEMBL11431223 0.87 NR3C2 (0.61) HIF1APGRSERPINA6LMNAAR
SCHEMBL11430689 0.86 PGR (0.65) HIF1APGRSERPINA6LMNAAR
SCHEMBL13368121 0.86 HIF1A (0.84) HIF1APGRSERPINA6LMNAAR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8524697-B2 C20-C21 substituted glucocorticoid receptor agonists MERCK SHARP & DOHME CORP. (US) 2013-09-03 — — US disclosed
US-8524697-B2 C20-C21 substituted glucocorticoid receptor agonists MERCK SHARP & DOHME CORP. (US) 2013-09-03 — — US disclosed
US-20110182828-A1 C20-C21 SUBSTITUTED GLUCOCORTICOID RECEPTOR AGONISTS SCHERING CORPORATION (US) 2011-07-28 — — US disclosed
US-20110182828-A1 C20-C21 SUBSTITUTED GLUCOCORTICOID RECEPTOR AGONISTS SCHERING CORPORATION (US) 2011-07-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110182828-A1 C20-C21 SUBSTITUTED GLUCOCORTICOID RECEPTOR AGONISTS NR3C1, MC2R, NR3C2 HIF1A 3951/4885PGR 318/4885SERPINA6 265/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback